Latin America and the Caribbean Hub Source: Globocan 2020

Latin America and the Caribbean Hub Source: Globocan 2020

Latin America and the Caribbean Hub Source: Globocan 2020 Number of new cases in 2020, both sexes, all ages Geography Prostate 206 447 (14.4%) Breast 204 944 (14.3%) Other cancers Colorectum 729 831 (50.9%) 131 394 (9.2%) Lung 95 314 (6.6%) Stomach 65 589 (4.6%) Total: 1 433 519 Number of new cases in 2020, males, all ages Numbers at a glance Total population Prostate 206 447 (29.4%) 633392345 Other cancers 310 245 (44.2%) Number of new cases Colorectum 65 411 (9.3%) Lung 55 965 (8%) 1433519 Number of deaths Bladder Stomach 24 027 (3.4%) 39 299 (5.6%) Total: 701 394 690671 Number of new cases in 2020, females, all ages Number of prevalent cases (5-year) Breast 3760911 204 944 (28%) Other cancers Data source and methods 312 995 (42.8%) Colorectum 65 983 (9%) Incidence Cervix uteri Population weighted average of the rates of the group- 57 748 (7.9%) specific countries included in GLOBOCAN 2020. Mortality Lung Thyroid 39 349 (5.4%) 51 106 (7%) Population weighted average of the rates of the group- specific countries included in GLOBOCAN 2020. Total: 732 125 Prevalence Summary statistic 2020 Sum of group-specific prevalent cases. Males Females Both sexes Populations included Population 311 494 138 321 898 202 633 392 345 Number of new cancer cases 701 394 732 125 1 433 519 Argentina, Bolivia, Plurinational State of, Brazil, Chile, Age-standardized incidence rate (World) 199.5 179.5 187.0 Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, Risk of developing cancer before the age of 75 years (%) 20.5 17.7 18.9 El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela, Number of cancer deaths 353 350 337 321 690 671 Bolivarian Republic of Age-standardized mortality rate (World) 97.7 77.9 86.2 Risk of dying from cancer before the age of 75 years (%) 9.9 8.1 8.9 5-year prevalent cases 1 777 144 1 983 767 3 760 911 Top 5 most frequent cancers excluding non-melanoma skin cancer Prostate Breast Prostate (ranked by cases) Colorectum Colorectum Breast Lung Cervix uteri Colorectum Stomach Thyroid Lung Bladder Lung Stomach The Global Cancer Observatory - All Rights Reserved - March, 2021. Page 1 Latin America and the Caribbean Hub Source: Globocan Incidence, Mortality and Prevalence by cancer site New cases Deaths 5-year prevalence (all ages) Cancer Number Rank (%) Cum.risk Number Rank (%) Cum.risk Number Prop. (per 100 000) Prostate 206 447 1 14.4 7.24 53 688 3 7.8 1.10 688 536 221.04 Breast 204 944 2 14.3 5.67 55 593 2 8.0 1.44 696 056 216.23 Lung 95 314 3 6.6 1.45 84 586 1 12.2 1.26 104 343 16.47 Colon 87 013 4 6.1 1.23 48 947 5 7.1 0.63 218 010 34.42 Stomach 65 589 5 4.6 0.93 51 714 4 7.5 0.70 92 936 14.67 Thyroid 62 853 6 4.4 0.88 4 343 24 0.63 0.06 208 091 32.85 Cervix uteri 57 748 7 4.0 1.52 30 454 8 4.4 0.80 151 597 47.09 Rectum 39 192 8 2.7 0.58 16 892 13 2.4 0.23 106 332 16.79 Non-Hodgkin lymphoma 38 901 9 2.7 0.56 18 590 11 2.7 0.26 110 517 17.45 Liver 38 191 10 2.7 0.55 36 318 6 5.3 0.52 38 330 6.05 Leukaemia 37 354 11 2.6 0.47 26 935 9 3.9 0.33 106 830 16.87 Pancreas 36 403 12 2.5 0.51 35 122 7 5.1 0.49 27 680 4.37 Kidney 35 567 13 2.5 0.55 15 619 14 2.3 0.23 93 959 14.83 Bladder 33 236 14 2.3 0.47 12 790 16 1.9 0.14 92 866 14.66 Corpus uteri 32 098 15 2.2 0.98 8 324 19 1.2 0.24 102 212 31.75 Brain, central nervous system 25 602 16 1.8 0.36 21 980 10 3.2 0.32 68 496 10.81 Ovary 22 887 17 1.6 0.63 14 802 15 2.1 0.41 60 801 18.89 Melanoma of skin 18 766 18 1.3 0.25 5 616 22 0.81 0.07 55 364 8.74 Oesophagus 18 581 19 1.3 0.28 17 387 12 2.5 0.26 19 662 3.10 Lip, oral cavity 17 556 20 1.2 0.26 7 389 20 1.1 0.11 46 712 7.37 Larynx 15 834 21 1.1 0.26 10 031 18 1.5 0.16 45 313 7.15 Multiple myeloma 14 640 22 1.0 0.23 10 889 17 1.6 0.17 35 693 5.64 Testis 13 537 23 0.94 0.29 2 116 26 0.31 0.05 48 663 15.62 Hodgkin lymphoma 10 489 24 0.73 0.13 2 791 25 0.40 0.04 35 072 5.54 Gallbladder 9 818 25 0.68 0.14 6 343 21 0.92 0.09 11 391 1.80 Oropharynx 8 689 26 0.61 0.13 4 802 23 0.70 0.07 21 766 3.44 Anus 5 189 27 0.36 0.08 1 335 29 0.19 0.02 14 068 2.22 Penis 4 873 28 0.34 0.13 1 592 27 0.23 0.04 14 366 4.61 Salivary glands 4 087 29 0.29 0.06 1 234 30 0.18 0.02 12 307 1.94 Vulva 3 786 30 0.26 0.09 1 375 28 0.20 0.03 10 715 3.33 Kaposi sarcoma 2 799 31 0.20 0.03 553 34 0.08 0.01 8 084 1.28 Hypopharynx 2 384 32 0.17 0.04 1 059 33 0.15 0.02 3 885 0.61 Nasopharynx 1 975 33 0.14 0.03 1 128 31 0.16 0.02 5 731 0.90 Vagina 1 396 34 0.10 0.04 479 35 0.07 0.01 3 594 1.12 Mesothelioma 1 231 35 0.09 0.02 1 076 32 0.16 0.02 1 551 0.24 All cancer sites 1 433 519 - - 18.91 690 671 - - 8.93 3 760 911 593.8 Age-standardized (World) incidence rates per sex, top 10 cancers Males Females Prostate 58.5 Breast 52.1 Colorectum 18.5 15.1 Lung 15.7 9.1 Thyroid 3.4 13.7 Stomach 11.0 6.0 Cervix uteri 14.9 Leukaemia 6.3 4.7 Non-Hodgkin lymphoma 6.3 4.3 Kidney 6.4 3.4 60 40 20 0 20 40 60 ASR (World) per 100 000 Age-standardized (World) incidence and mortality rates, top 10 cancers Incidence Mortality Prostate 58.5 13.7 Breast 52.1 13.3 Colorectum 16.7 8.2 Cervix uteri 14.9 7.5 Lung 12.0 10.6 Thyroid 8.8 0.53 Stomach 8.2 6.4 Corpus uteri 8.1 1.9 Ovary 5.8 3.6 Leukaemia 5.5 3.7 60 40 20 0 20 40 60 ASR (World) per 100 000 The Global Cancer Observatory - All Rights Reserved - March, 2021. Page 2.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    2 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us